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The administration of high doses of non-steroidal anti-inflammatory drugs 
(NSAID), such as tolfenamic acid (TA), has undesirable effects on different or-
gans. Some novel biomarkers have been reported that can determine the gastroin-
testinal and renal injury caused by a high dose of NSAIDs or other toxic sub-
stances. This study was aimed at determining the changes in gastrointestinal 
(TFF2 and HYP), renal (NGAL and KIM-1) and cardiac (cTn-I, CK-MB) injury 
markers after the use of increasing intravenous doses of TA in sheep. TA was 
administered intravenously to groups of six sheep each, at the dose levels of 0 
(Group 0, i.e., G0), 2 (G2), 4 (G4), 8 (G8) and 16 (G16) mg/kg. The concentra-
tions of the studied biomarkers were measured at 3, 9, 18 and 36 h after admin-
istration of TA. The TFF2 and NGAL concentrations in G16 were found to be 
significantly higher (P < 0.05) than in the other groups except for G8 at different 
sampling times. HYP concentration in G16 was observed to be significantly (P < 
0.05) lower than that in all other groups at 36 h. KIM-1 level in G16 was signifi-
cantly (P < 0.05) higher than in all other groups at different sampling times. An 
increase in the renal markers, KIM-1 and NGAL, in G8 was observed before any 
change in plasma creatinine and urea. The cardiac marker cTn-I in G16 was sig-
nificantly (P < 0.05) higher than in other groups at different sampling times. The 
results showed that the novel biomarkers (HYP, TFF2, NGAL, and KIM-1) can 
be used to determine gastric and renal injury in sheep.  
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Non-steroidal anti-inflammatory drugs (NSAIDs), including tolfenamic 
acid (TA), are one of the most commonly used classes of drugs in humans and 
animals. NSAIDs have analgesic, antipyretic, and anti-inflammatory properties. 
TA has been approved for use in mastitis, metritis, and respiratory system infec-
tions in cattle and for musculoskeletal disorders and the reduction of postopera-
tive pain in dogs and cats (CVMP, 1997). NSAIDs are associated with adverse 
effects like renal failure, gastric ulcers, and bleeding disorders after injuries 
and/or surgical interventions (Curry et al., 2005). There are classic/conventional 
and novel biomarkers to determine the gastrointestinal, renal, and cardiac inju-
ries. The increasing concentration in trefoil factor 2 (TFF2), which is a peptide 
(Poulsen et al., 1999) and the decreasing concentration in hydroxyproline (HYP), 
which is an amino acid (Takeuchi et al., 2014), have been used to determine the 
gastrointestinal damage. TFF2 is expressed and secreted preferentially by gastric 
mucous neck cells (Zhang et al., 2016) and plays a key role in the maintenance of 
mucosal integrity (Kaise et al., 2013). HYP is a characteristic amino acid of col-
lagen and is mostly used as an indicator to determine the amount of collagen 
(Zhang et al., 2016) in gastric (Takeuchi et al., 2013) and lung tissue (Shao et al., 
2015). Decreased concentrations of HYP in stomach tissue extract and serum 
have been reported in NSAID-induced gastric ulcers (Takeuchi et al., 2013). It 
has been reported that these changes are due to the activation of collagenase by 
NSAID-induced mitochondrial depression and by lesions present in the stomach. 
There is a significant correlation between the changes in HYP levels in the stom-
ach and serum (Takeuchi et al., 2014).  
Early diagnosis of NSAID-induced renal injury is important but difficult. 
In clinical settings, the follow-up of patients is mainly based on the detection of 
serum creatinine (Cr) and blood urea, and on urinalysis (Fuchs and Hewitt, 
2011). Owing to the poor sensitivity and specificity of these traditional markers, 
new indicators are required for a more accurate and early detection of kidney 
damage associated with the side effects of NSAIDs (Sistare et al., 2010). In renal 
tissue injuries, many protein products such as neutrophil gelatinase-associated 
lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) appear in the blood and 
may serve as new biomarkers for the early detection of acute kidney injury (AKI) 
(Ozer et al., 2010; Luo et al., 2016). NGAL, a small protein from the lipocalin 
family, is expressed exclusively in the tubular epithelium of the distal nephron 
and is released by tubular epithelial cells during AKI (Zhao et al., 2010). NGAL 
was used to determine the risk of AKI in dogs (Diniz et al., 2010). KIM-1 may 
facilitate accurate prediction of nephrotoxicity in the preclinical stages of drug 
screening (Vaidya et al., 2010). 
The US Food and Drug Administration has mandated a ‘black box’ warn-
ing for all NSAIDs to describe the potential risk of serious cardiovascular events 
(Hermann, 2009). Traditional cardiac biomarkers like troponin-I (cTn-I) and 
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Creatine Kinase-MB fraction (CK-MB) can be used to detect cardiac injury in 
animals (Undhad et al., 2012). 
The aim of this study was to establish the superiority of novel gastric 
(TFF2 and HYP) and renal (NGAL and KIM-1) tissue damage biomarkers over 
the conventional renal function markers (Cr and urea) and heart tissue damage 
markers (cTn-I and CK-MB) in the blood plasma of sheep in an experimental 
model where tissue damage was induced by increasing doses of TA (2, 4, 8 and 
16 mg/kg). 
 
Materials and methods 
Animals 
Thirty clinically healthy Akkaraman female sheep weighing between 38 and 
45 kg and aged 2–3 years were selected for the study. The animals were checked 
clinically and haematologically before and after the one-week adaptation period. 
The healthy-looking animals were subjected to a check-up profile [creatinine, urea, 
alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate amino-
transferase (AST), gamma glutamyltransferase (GGT) and total protein (Table 2)] 
and those with normal values were randomly assigned to five equal groups (G0, 
G2, G4, G8, and G16). During the experimental period, all sheep were kept to-
gether, outdoors during the day and housed at night. The animals were fed daily on 
a ryegrass and clover hay mix along with a supplementary concentrate. Water was 
given ad libitum. The experimental procedures were approved by the Ethics Com-
mittee of the Mehmet Akif Ersoy University (2017–280). 
Experimental design 
In the study, the animals were randomly assigned to five equal groups. 
Tolfenamic acid (Tolfine, Novakim, Kocaeli, Turkey) was administered intrave-
nously to each group at single dose levels of 2 (G2), 4 (G4), 8 (G8), and 16 
(G16) mg/kg. The control group (G0) received only sterile physiological saline 
solution in a similar manner. The blood samples were collected into tubes con-
taining heparin at 3, 9, 18, and 36 h post-dosing, via a catheter placed in the right 
jugular vein. Blood samples were centrifuged (10 min at 2500 × g) and the plas-
ma was stored at –70 °C until assayed. 
Laboratory analysis 
The concentrations of gastrointestinal (TFF2 and HYP) and renal (NGAL 
and KIM-1) markers in the plasma were determined using commercially availa-
ble sheep specific ELISA kits (MyBiosource, San Diego, USA) following the 
manufacturer’s recommendation. Absorption was determined using a microplate 
reader (ELX800 universal microplate reader, BIOTEK®, USA). The validation 
data provided by the manufacturer of the ELISA kits were used in the study. For  
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NGAL and KIM-1, the intra-assay and inter-assay coefficients of variation (CV) 
were < 10% and the minimum detectable concentration (MDC) was 18.75 pg/mL. 
For TFF2, the intra-assay and inter-assay CV were < 10% and MDC was 
15.625 pg/mL. For HYP, the intra-assay and inter-assay CV were ≤ 15% and 
MDC was 0.1 μg/mL. For the detection of heart damage markers (CK-MB, cTn-I) 
Siemens Advia Centaur XP (Erlangen, Germany) was used. Cr and BUN were 
measured with commercial kits using an autoanalyzer (ILab-300 plus, Instrumen-
tation Laboratory, Milano, Italy). 
Statistical analysis 
Descriptive statistics for each variable were calculated and presented as 
‘Mean ± Standard Error of Mean’. Data were subjected to two-way mixed design 
analysis of variance (ANOVA) using a General Linear Model for repeated 
measures procedure to examine the effect of ‘group’ and ‘time’ for the measure-
ments obtained. The model included ‘group’ and ‘time’ as the main effect terms 
and ‘group × time’ as the interaction effect term. In cases where Mauchly’s test 
revealed that the assumption of sphericity was violated, the Greenhouse–Geisser 
adjustment was applied. Post-hoc testing for significant interactions was per-
formed using the simple effect analysis with the Bonferroni adjustment. In cases 
where the interaction terms were not statistically significant, contrasts were used 
to analyse the main effects. A probability value of less than 0.05 was considered 
significant, unless otherwise mentioned. SPSS 14.01 was used for all statistical 
analyses. 
 
Results 
The concentrations of biomarkers (TFF2, HYP, NGAL, KIM-1, Cr, urea, 
CK-MB and cTn-I) are shown in Table 1. The statistically (P < 0.05) highest 
concentrations of TFF2, NGAL, KIM-1, CK-MB, cTnI and lowest concentra-
tions of HYP were detected in G16 (Table 1). 
A substantial increase in TFF2 was found in G16 (282%) and G8 (219%) 
compared to G0, while the increase in TFF2 was less severe in G4 (141%) and 
G2 (53%). On the other hand, a 50% decrease in HYP was found in G16 com-
pared to that obtained in G0, whereas this decrease was less severe in G8 (29%), 
G4 (5%) and G2 (3%). 
Compared with G0, the concentrations of NGAL and KIM-1 were signifi-
cantly increased in G16 (295 and 726%, respectively) and G8 (220 and 530%, 
respectively), while their concentrations were found to be lower in G4 (161 and 
188%, respectively) and G2 (54 and 49%, respectively). In a manner similar to 
the elevation in NGAL (295%) and KIM-1 (726%) concentrations, the levels of 
creatinine (363%) were increased in G16 at the same time. The increases in renal 
parameters including NGAL (220%) and KIM-1 (530%) were more evident in 
G8, but this increase was just 5% in a conventional parameter such as creatinine. 
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Discussion 
It has been shown that novel biomarkers such as HYP, TFF2, NGAL, and 
KIM-1 can be used to determine the severity of gastric and renal injury in sheep. 
The alterations in the concentrations of HYP, TFF2, NGAL, KIM-1, Cr, BUN, 
cTn-I, and CK-MB in the blood plasma showed that TA at a dose of 16 mg/kg 
caused gastrointestinal, renal, and cardiac damages in sheep. In this study, the high 
doses (8 and 16 mg/kg) were used only to describe the changes in the investigat-
ed parameters, not for the confirmation of the well-known dose of 2 (and 4) mg/kg 
in sheep. 
Indomethacin, another NSAID, has been shown to significantly increase 
gastric ulceration in mice deficient in TFF2 as compared to that in wild-type 
mice (Farrel et al., 2002). The mRNA expression of TFF2 has been found to be 
increased within a few minutes of induction of ulcers in rats in an experimental 
gastric ulcer model (Alison et al., 1995). In the present study, TFF2 in G16 was 
found to be statistically higher (P < 0.05) than in G0, G2, and G4 after 3 and 9 h 
and in G0 and G2 after 18 and 36 h. We found that TFF2 concentration in the 
blood plasma in other TA dose groups, except for G2, increased from after 3 h 
(P < 0.05, Table 1). An increase in TFF2 was found in G16 (282%) and G8 
(219%) compared to G0, while the increase in TFF2 was less severe in the other 
groups. The major mechanism of NSAIDs in causing gastro-duodenal ulceration 
and bleeding is the suppression of PG synthesis. Following the inhibition of PG 
synthesis, gastrointestinal tissues become more sensitive to the damage caused 
by gastric acid. Due to the inhibition of PGs, the restoration of structure and 
function of the mucosa may decline after the damage (Wallace, 2008). The role 
of TFF2 in mucosal healing and repair is consistent with its ability to inhibit gas-
tric acid secretion. After the gastric mucosal injury, TFF2 expression increases 
rapidly, which is likely to cause a reduction in the production of gastric acid 
(Farrel et al., 2002). HYP is another novel biomarker that can detect gastric dam-
age associated with NSAIDs. It has been reported that the metabolic profiles of 
serum and gastric tissue extracts of rats show a decrease in HYP concentrations 
after treatment with NSAIDs (Takeuchi et al., 2013). In addition, a significant 
correlation was observed between the decrease in proline and HYP concentra-
tions in serum and gastric tissue extracts. HYP has been demonstrated to be a 
new, non-invasive biomarker for the monitoring of NSAID-induced gastric dam-
age and a promising alternative of the current invasive endoscopic procedures. 
The decrease in proline and HYP concentrations reflects an increased colla-
genase activity following a decrease in the collagen level of the stomach tissue 
(Takeuchi et al., 2013). A previous study (Takeuchi et al., 2014) also reported 
that HYP is a serum biomarker, which can predict NSAID-induced gastric dam-
age in rats. In the present study, HYP level in G16 was found to be lower than 
that in other groups after 3 h. Further, it was statistically lower than that in G0 af-
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ter 9 and 18 h or that in G2 after 18 h and was lower than in all other groups after 
36 h. A decrease in HYP was found in G16 (50%) compared to that obtained in 
G0, whereas this decrease was less severe in the other groups. The decrease in 
HYP level seen in G16 may be associated with a decrease in the amount of colla-
gen due to the gastric damage caused by TA administered at a dose of 16 mg/kg. 
The percentage of the increase and decrease in these biomarkers according to the 
drug dose has also changed in the same direction. The data from the present 
study suggest that TFF2 and HYP may be used as early biomarkers for gastric 
mucosal damage caused by NSAIDs in sheep. However, further studies are need-
ed to clarify the limitations of these biomarkers by using other measurement 
methods in tissue and plasma. 
NSAIDs may impair renal autoregulation under conditions of hypovolae-
mia and hypotension. It has been reported that a decrease in renal blood flow and 
function may lead to acute renal failure and death in dogs and cats (Lascelles et 
al., 2007). It has also been reported that patients who were administered a high 
daily dose of NSAIDs showed a greater risk for AKI than those who were ad-
ministered a low to medium dose (Huerta et al., 2005). In a gentamicin-induced 
renal injury model, Luo et al. (2016) determined that NGAL and KIM-1 gene 
expressions were the earliest responses of the kidney damage. Alterations in the 
concentrations of KIM-1 and NGAL had been detected even before significant 
changes were observed in other clinical chemistry parameters. In the present 
study, an increase in the concentrations of KIM-1 and NGAL was observed with-
in 3 h. The increase in KIM-1 and NGAL concentrations in G8 was seen as early 
as after 3 h, before any changes occurred in the conventional parameters (Cr and 
BUN) in this group (Table 1). This indicates that NGAL and KIM-1 reflect renal 
damage early and accurately (Vaidya et al., 2010; Luo et al., 2016). In addition, 
the level of Cr increased with NGAL and KIM-1 at the same time and this may 
indicate serious damage to the kidneys at a dose of 16 mg/kg of TA. The use of 
high doses of NSAIDs daily is more likely to cause renal injury (Huerta et al., 
2005). Further, alterations in the concentration of NGAL were one of the earliest 
effects observed in the kidneys of animals treated with the 4 mg/kg dose of TA 
(G4) after 9 h. However, the earliest effects in KIM-1 in G4 were observed only 
after 18 h. A similar elevation in the concentrations of NGAL (295%) and KIM-1 
(726%) with the levels of creatinine (363%) was seen in G16. The increases in 
renal parameters including NGAL (220%) and KIM-1 (530%) were more evident 
in the G8 group, but this increase was just 5% in a conventional parameter such 
as creatinine. These data may suggest that NGAL is an earlier marker of renal in-
jury than KIM-1. The results obtained in a previous study (Noyan et al., 2015) 
support the use of urinary NGAL concentrations rather than urinary KIM-1 as an 
early marker for renal hydronephrosis. However, this study had some limitations 
such as the examination of microalbuminuria and the low number of animals in 
each group. 
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Table 2 
Check-up profile of the groups at baseline level (mean ± SE) 
Groups Creatinine (μmol/L) 
Urea 
(mmol/mL) 
ALP  
(U/L) 
ALT  
(U/L) 
AST  
(U/L) 
GGT  
(U/L) 
Total protein 
(g/L) 
G0 45 ± 1.5 7 ± 0.2 85 ± 16 12 ± 1.4 91 ± 13 46 ± 5.5 69 ± 1 
G2 47 ± 2.6 7 ± 0.7 87 ± 12 13 ± 2.7 89 ± 19 44 ± 4.6 69 ± 2.9 
G4 49 ± 3 6 ± 0.5 78 ± 8 13 ± 1.2 78 ± 14 44 ± 6.2 70 ± 1.4 
G8 47 ± 3.1 7 ± 0.4 89 ± 8 14 ± 2.8 95 ± 18 46 ± 4.4 70 ± 2.1 
G16 46 ± 3.2 6 ± 0.2 92 ± 11 17 ± 3.2 91 ± 21 41 ± 2.7 75 ± 2.8 
 
The effects of NSAIDs on the coronary vasculature can be ascertained by 
the relative inhibition of the COX enzymes (COX-1 and COX-2). These en-
zymes show counterproductive effects on the coronary vasculature (Cheetham et 
al., 2008). In vitro data support that TA has a COX-1-sparing (COX-2-selective) 
activity (Budsberg, 2009). In the present study, the role of widely applied bi-
omarkers such as cTn-I and CK-MB in the blood plasma was evaluated in the de-
tection of cardiac injury. The cTn-I level in G16 was statistically higher than that 
in G0, G2, G4, and G8 after 9 and 36 h. CK-MB activity in G16 was found to be 
statistically higher than that in G0 and G2 after 18 h and in G0, G2, G4 and G8 
after 36 h. Biomarkers such as cTn-I and CK-MB may be used to determine the 
cardiac damage at a high dose of NSAIDs such as TA (16 mg/kg) in sheep exper-
imental study models. 
In conclusion, the changes in the concentrations of novel biomarkers 
(TFF2, HYP, NGAL, and KIM-1) in the blood plasma might be used for the ear-
ly diagnosis of gastric and renal damage in sheep. However, further studies are 
required to prove the applicability of these biomarkers for diagnosing other tissue 
damages than TA-related ones.  
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